Posted in | News

Cementos Pacasmayo Commences Cement Production at New Piura Facility

Cementos Pacasmayo S.A.A. and subsidiaries (“the Company” or “Cementos Pacasmayo”), a leading Peruvian supplier of cement and construction materials, announced today that it has begun commercial production from its new cutting edge Piura facility.

The first ton of cement from the Piura facility was produced and shipped today. The Piura plant will be the most modern cement plant in Latin America, featuring a multi-fuel kiln. Final capacity will be 1.6 million tons of cement per year, and 1.0 million tons of clinker per year.

“I am delighted to announce the beginning of commercial operations at the Piura plant, an important milestone for Cementos Pacasmayo and the Peruvian cement industry,” said Humberto Nadal, Chief Executive Officer of Cementos Pacasmayo. “Piura will offer our clients high-quality cement, with improved logistics, while simultaneously lowering our cost of production.

“We continue to execute this important project on time and under budget, demonstrating our expertise in large-scale, advanced facilities. We look forward to moving the plant along its production curve, creating value for all stakeholders,” Mr. Nadal concluded.

About Cementos Pacasmayo S.A.A.

Cementos Pacasmayo S.A.A. is a leading Peruvian cement company, and the only cement manufacturer in the Northern region of Peru. In February 2012, the Company’s shares were listed on The New York Stock Exchange - Euronext under the ticker symbol "CPAC". With more than 57 years of operating history, the Company produces, distributes and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. Cementos Pacasmayo’s products are primarily used in construction, which has been one of the fastest-growing segments of the Peruvian economy in recent years. The Company also produces and sells quicklime for use in mining operations.

Source: http://www.cementospacasmayo.com.pe/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.